These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23764533)

  • 1. Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods.
    Cook MC; Bliu A; Kunkel JP
    Vaccine; 2013 Aug; 31(36):3702-11. PubMed ID: 23764533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serogroup quantitation of multivalent polysaccharide and polysaccharide-conjugate meningococcal vaccines from China.
    Cook MC; Gibeault S; Filippenko V; Ye Q; Wang J; Kunkel JP
    Biologicals; 2013 Jul; 41(4):261-8. PubMed ID: 23665303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of each serogroup polysaccharide of Neisseria meningitidis in A/C/Y/W-135-DT conjugate vaccine by high-performance anion-exchange chromatography-pulsed amperometric detection analysis.
    Gudlavalleti SK; Crawford EN; Harder JD; Reddy JR
    Anal Chem; 2014 Jun; 86(11):5383-90. PubMed ID: 24810004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative stability of meningococcal serogroup A and X polysaccharides.
    Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
    Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a new method for the quantitative analysis of the extracellular polysaccharide of Neisseria meningitidis serogroup A by use of high-performance anion-exchange chromatography with pulsed-amperometric detection.
    Ricci S; Bardotti A; D'Ascenzi S; Ravenscroft N
    Vaccine; 2001 Feb; 19(15-16):1989-97. PubMed ID: 11228369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An integrity assay for a meningococcal type B conjugate vaccine.
    Turula VE; Kim J; Michon F; Pankratz J; Zhang Y; Yoo C
    Anal Biochem; 2004 Apr; 327(2):261-70. PubMed ID: 15051544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acid hydrolysis conditions for quantification of meningococcal X polysaccharide in a pentavalent vaccine using HPAEC-PAD/ESI-MS.
    Ghosh S; Pawar R; Kangralkar V; Mallya AD; Dhere RM; Bolgiano B; Ravenscroft N
    Anal Biochem; 2023 Dec; 683():115363. PubMed ID: 37866526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saccharide dosage content of meningococcal polysaccharide conjugate vaccines determined using WHO International Standards for serogroup A, C, W, Y and X polysaccharides.
    Gao F; Beresford N; Lockyer K; Burkin K; Rigsby P; Bolgiano B
    Biologicals; 2021 Apr; 70():53-58. PubMed ID: 33518432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of free polysaccharide in meningococcal polysaccharide-diphtheria toxoid conjugate vaccines.
    Lei QP; Shannon AG; Heller RK; Lamb DH
    Dev Biol (Basel); 2000; 103():259-64. PubMed ID: 11214246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines.
    Reyes F; Otero O; Cuello M; Amin N; García L; Cardoso D; Camacho F
    J Immunol Methods; 2014 May; 407():58-62. PubMed ID: 24727145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM
    Beresford NJ; Martino A; Feavers IM; Corbel MJ; Bai X; Borrow R; Bolgiano B
    Vaccine; 2017 Jun; 35(28):3598-3606. PubMed ID: 28408122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Size determination of bacterial capsular oligosaccharides used to prepare conjugate vaccines against Neisseria meningitidis groups Y and W135.
    Bardotti A; Averani G; Berti F; Berti S; Galli C; Giannini S; Fabbri B; Proietti D; Ravenscroft N; Ricci S
    Vaccine; 2005 Mar; 23(16):1887-99. PubMed ID: 15734061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel monoclonal antibody to Neisseria meningitidis serogroup X capsular polysaccharide and its potential use in quantitation of meningococcal vaccines.
    Reyes F; Otero O; Camacho F; Amin N; Ramírez F; Valdés Y; Acevedo R; García L; Cardoso D; Cuello M
    Biologicals; 2014 Nov; 42(6):312-5. PubMed ID: 25218518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Neisseria meningitidis serogroup W135 polysaccharide-tetanus toxoid conjugate vaccines made by periodate activation of O-acetylated, non-O-acetylated and chemically de-O-acetylated polysaccharide.
    Gudlavalleti SK; Lee CH; Norris SE; Paul-Satyaseela M; Vann WF; Frasch CE
    Vaccine; 2007 Nov; 25(46):7972-80. PubMed ID: 17936445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Control and lot release of meningococcal group C conjugate vaccines.
    Suker J; Feavers IM; Corbel MJ; Jones C; Bolgiano B
    Expert Rev Vaccines; 2004 Oct; 3(5):533-40. PubMed ID: 15485333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.
    McVernon J; Nolan T; Richmond P; Reynolds G; Nissen M; Lambert SB; Marshall H; Papa T; Rehm C
    Pediatr Infect Dis J; 2012 Jan; 31(1):e15-23. PubMed ID: 22094636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meningococcal vaccines.
    Danzig L
    Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of meningococcal polysaccharides by capillary zone electrophoresis.
    Lamb DH; Lei QP; Hakim N; Rizzo S; Cash P
    Anal Biochem; 2005 Mar; 338(2):263-9. PubMed ID: 15745746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meningococcal X polysaccharide quantification by high-performance anion-exchange chromatography using synthetic N-acetylglucosamine-4-phosphate as standard.
    Micoli F; Adamo R; Proietti D; Gavini M; Romano MR; MacLennan CA; Costantino P; Berti F
    Anal Biochem; 2013 Nov; 442(2):259-61. PubMed ID: 23938776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physicochemical characterisation of glycoconjugate vaccines for prevention of meningococcal diseases.
    Bardotti A; Averani G; Berti F; Berti S; Carinci V; D'Ascenzi S; Fabbri B; Giannini S; Giannozzi A; Magagnoli C; Proietti D; Norelli F; Rappuoli R; Ricci S; Costantino P
    Vaccine; 2008 Apr; 26(18):2284-96. PubMed ID: 18378363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.